{
    "nct_id": "NCT05547386",
    "official_title": "68Ga-PSMA-11 PET/CT for Screening Prior to 177Lu-PSMA-617 Therapy",
    "inclusion_criteria": "* An adult male patient who is actively under the care of a medical oncology, radiation oncology or urology physician at Mayo Clinic\n* An adult male patient who is deemed eligible (or potentially/likely eligible) for PSMA-targeted radionuclide therapy by a nuclear medicine physician or Radiologist in the nuclear medicine therapy practice, or by the Prostate Theranostic Tumor Board (PTuB)\n\n  * Eligibility will be documented in the medical record by the clinical practice\n  * It is acceptable for the patient to be eligible for PSMA-targeted radionuclide therapy in all regards except for having completed a PSMA-targeted PET scan showing PSMA-positive prostate cancer\n  * It is acceptable for a patient to be potentially eligible for therapy, but have a relative contraindication, such as a minor laboratory abnormality, and be on the list for discussion at the PTuB in the future\n* An adult male patient who has not received a 68Ga-PSMA-11 PET/CT or PET/magnetic resonance (MR), or for whom a repeat 68Ga-PSMA-11 PET/CT exam is needed per the clinical practice to ensure eligibility\n* An adult male patient who does not otherwise have access to a reimbursable clinical 68Ga-PSMA-11 PET scan\n* An adult above the ages of 18\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* A patient who is unable to consent per Mayo guidelines\n* A patient who is unable to lay still, or otherwise successfully complete the imaging exam",
    "miscellaneous_criteria": ""
}